Epilepsy Research
Volume 28, Issue 1 , Pages 11-15 , July 1997

Pharmacokinetics and muscle histopathology of intramuscular valproate

Received 17 February 1997 ,Revised 26 March 1997 ,Accepted 27 March 1997.

References 

  1. Autefage A, Fayolle P, Toutain PL. Distribution of material injected intramuscularly in dogs. Am J Vet Res. 1990;51(6):901–904
  2. Delorenzo R, Towe A, Pellock J, Ko D. Status epilepticus in children, adults and the elderly. Epilepsia. 1992;33(Suppl 4):S15–S25
  3. Frey HH, Löscher W. Pharmacokinetics of anti-epileptic drugs in the dog: a review [Review]. J Vet Pharmacol Ther. 1985;8(3):219–233
  4. Gilman AG, Rall TW et al. The Pharmacological Basis of Therapeutics, 8th ed. pp. 450–453.
  5. Hauser WA. Status epilepticus:epidemiologic considerations. Neurology. 1990;40(Suppl 2):9–12
  6. Löscher W. Plasma levels of valproic acid and its metabolites during continued treatment in dogs. J Vet Pharmacol Ther. 1981;4(2):111–119
  7. Ramsay RE, Uthman B, Leppik IE, Pellock J, Wilder BJ, Morris D. The tolerability and safety of valproate sodium injection given as an intravenous infusion. J Epilepsy 1997; in press.

PII: S0920-1211(97)00027-2

Epilepsy Research
Volume 28, Issue 1 , Pages 11-15 , July 1997

Article Tools

* Image Usage & Resolution